Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Supraspinal antinociceptive activity of the alpha2B-adrenoceptor agonist A-1262543

Nov. 14, 2013

Innate Pharma presents a novel cytotoxic antibody against KIR3DL2-expressing cancers

Nov. 13, 2013

ME-3398, a novel PDE10A inhibitor for the treatment of schizophrenia

Nov. 13, 2013

ChemoCentryx describes novel small-molecule inhibitors of CCR1 and CCR6

Nov. 13, 2013

Dual D2 and H3 blockade as a putative strategy for schizophrenia: Angita's AG-0098

Nov. 13, 2013

KKHP-60159 reported to have ideal antipsychotic profile

Nov. 13, 2013

DCBCI-0901 shows promising activity in in vitro and in vivo cancer models

Nov. 13, 2013

SIRT1 activation as a putative strategy for the treatment of Huntington's disease

Nov. 12, 2013

Bispecific TNF/IL-17A inhibitor engineered for rheumatoid arthritis

Nov. 12, 2013

Sanofi presents preclinical results for SAR-502250

Nov. 12, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...